PTPI
Petros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.00
+3.36%Sep 30, 2026, 21:13 UTC
Petros Pharmaceuticals, Inc. announced the resignations of Executive Chairman Joshua N. Silverman, directors Bruce T. Bernstein and Wayne R. Walker, and Chief Accounting Officer Robert Weinstein, and the termination of President and Chief Commercial Officer Fady Boctor, all effective September 30, 2026.
Jun 5, 2026, 00:00 UTC
Petros Pharmaceuticals granted restricted shares to Chairman Joshua Silverman, director Bruce Bernstein, President and Chief Commercial Officer Fady Boctor, and director Wayne Walker on June 5, 2026.